======= GMPR2 ======= == Gene Information == * **Official Symbol**: GMPR2 * **Official Name**: guanosine monophosphate reductase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51292|51292]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9P2T1|Q9P2T1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=GMPR2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GMPR2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/610781|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes an enzyme that catalyzes the irreversible and NADPH-dependent reductive deamination of guanosine monophosphate (GMP) to inosine monophosphate (IMP). The protein also functions in the re-utilization of free intracellular bases and purine nucleosides. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2017]. * **UniProt Summary**: Catalyzes the irreversible NADPH-dependent deamination of GMP to IMP. It functions in the conversion of nucleobase, nucleoside and nucleotide derivatives of G to A nucleotides, and in maintaining the intracellular balance of A and G nucleotides (PubMed:12009299, PubMed:12669231, PubMed:16359702, PubMed:22037469). Plays a role in modulating cellular differentiation (PubMed:12669231). {ECO:0000255|HAMAP- Rule:MF_03195, ECO:0000269|PubMed:12009299, ECO:0000269|PubMed:12669231, ECO:0000269|PubMed:16359702, ECO:0000269|PubMed:22037469}. |IMPDH| |GMP reductase activity| |GMP reductase complex| |purine ribonucleotide interconversion| |purine nucleotide interconversion| |purine-containing compound salvage| |GMP metabolic process| |purine nucleobase metabolic process| |nucleobase-containing small molecule interconversion| |cellular metabolic compound salvage| |purine ribonucleoside monophosphate metabolic process| |purine nucleoside monophosphate metabolic process| |guanosine-containing compound metabolic process| |nucleobase metabolic process| |ribonucleoside monophosphate metabolic process| |purine ribonucleoside metabolic process| |purine nucleoside metabolic process| |nucleoside monophosphate metabolic process| |ribonucleoside metabolic process| |nucleoside metabolic process| |glycosyl compound metabolic process| |purine-containing compound biosynthetic process| |purine ribonucleotide metabolic process| |ribonucleotide metabolic process| |purine nucleotide metabolic process| |ribose phosphate metabolic process| |purine-containing compound metabolic process| |nucleotide metabolic process| |nucleoside phosphate metabolic process| |nucleobase-containing small molecule metabolic process| |organophosphate metabolic process| |oxidation-reduction process| |carbohydrate derivative metabolic process| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |organic cyclic compound biosynthetic process| |organonitrogen compound biosynthetic process| |cellular nitrogen compound biosynthetic process| |small molecule metabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp54|Taxol 0.002μM R01 exp54]]|-1.74| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13322 * **Expression level (log2 read counts)**: 5.55 {{:chemogenomics:nalm6 dist.png?nolink |}}